May 4, 2020 — Olaris, a precision medicine company that is working to fundamentally change how diseases are treated, today announced that Olaris CEO and Founder Dr. Elizabeth O’Day will speak at Xcelerating Life Sciences Boston, an Xconomy virtual conference & networking event focused on biopharma’s future in digital health.

 

Xcelerating Life Sciences Boston brings together leaders from Boston’s biopharma industry for an afternoon of discussions around emerging therapies, regulatory environments, and personalized medicine. The digital event will take place on May 13, from 1–5 p.m. ET. 

 

Dr. O’Day will be joined by Biogen Senior Director of Applied Sciences and Clinical Technologies Katherine Fisher and Empiriko CEO and Founder Pam Randhawa on the panel, “Managing the Patient in the World of Personalized Medicine.” Panelists will discuss what is being done to improve patient delivery and how that can be balanced with concerns about data, devices, technology, and privacy. They will also explore  how patient outcome measurement and definitions of success in the field of precision medicine.  

 

To register for Xcelerating Life Sciences Boston, visit https://xconomy.com/xcelerating-life-sciences-boston/.

 

About Olaris

Olaris is working to fundamentally change how diseases are treated. The company’s metabolomics platform and machine learning algorithms produce Biomarkers of Response (BoR), which removes the guesswork when treating an individual patient’s disease. To learn more, visit www.olarisbor.com.